28 - 185 - RETINOIDS Flashcards
US FDA approved as oral therapy for CTCL
A. Tretinoin
B. Alitretinoin
C. Tazarotene
D. Bexarotene
D
Example of second generation retinoid
A. Alitretinoin
B. Adapalene
C. Acitretin
D. Tazarotene
C
Discontinuation of isotretinoin is warranted in which situation/s
A. Elevation of transaminases three times from the normal range
B. Triglyceride levels reaches 800mg/dl
C. A and B
D. None of the above
C
These medications can prolong the half-life of tretinoin locallt on the skin
A. Ketoconazole
B. Alcohol
C. Liazole
D. A and C
D
High incidence of neutropenia has been identified with this retinoid
A. Alitretinoin
B. Bexarotene
C. Acitretin
D. Etretinate
B
Most frequent laboratory abnormality seen with retinoid therapy
A. Serum lipid changes
B. Elevated transaminases
C. Elevated kidney function test
D. Increased FBS
A
any molecule that by itself or through metabolic conversion binds to and activates retinoic acid receptors
Retinoid
predominant retinoid receptors in human skin
retinoic acid receptor α (RAR-α),
RAR-γ,
retinoid X receptor α (RXR-α),
RXR-β
bind to retinoic acid–responsive elements and are responsible for retinoid signaling
RAR-γ/RXR-α heterodimers
Approved indications of topical retinoids
acne, psoriasis, cutaneous T-cell lymphoma, Kaposi sarcoma, melasma, photoaged skin
Approved indications of oral retinoids
acne, chronic hand eczema, psoriasis, and cutaneous T-cell lymphoma
Most concerning side effect of retinoids
Teratogenicity
First-generation retinoids
- all-trans-retinoic acid (tretinoin),
- 13-cis-retinoic acid (isotretinoin),
- 9-cis-retinoic acid (alitretinoin)
Second-generation retinoids
Etretinate
Acitretin
Third Generation Retinoids
Adapalene
Tazarotene
Bexarotene